November 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreDecember 26, 2025
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 238.65 billi...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreDecember 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreDecember 31, 2025
Market insights predict, the sequencing industry is expected to grow from USD 23.28 billion in 2025 to USD 173 billion by 2035, driven by a CAGR of 22.21%. The market is witnessing rapid growth due to increased applications in different industries....
December 30, 2025
The next-generation metabolic therapies market is witnessing strong expansion and is expected to generate revenue in the hundreds of millions during the forecast period from 2026 to 2035, driven by rising cases of metabolic disorders such as obesity, diabetes, NAFLD/NASH, and cardiometabolic syndrome....
December 30, 2025
According to market projections, the RNA analysis sector is expected to grow from USD 6.86 billion in 2025 to USD 23.9 billion by 2035, reflecting a CAGR of 13.36%. The RNA analysis market is growing due to increasing demand for personalized medicine. North America is leading due to its advanced research infrastructure and favorable government envi...
December 30, 2025
Market insights predict, the carrier screening industry is expected to grow from USD 3.09 billion in 2025 to USD 18.58 billion by 2035, driven by a CAGR of 19.65%. An immense growth in prenatal screening programs and early detection is mainly influencing the global market expansion. Whereas, the presence of robust healthcare policies and syst...
December 30, 2025
Based on market forecasts, the DNA methylation sector will expand from USD 2.05 billion in 2025 to USD 7.36 billion by 2035, experiencing a CAGR of 13.64%. The emerging trend of genomic imprinting and gene expression regulation drives the importance of DNA methylation. North America dominated the market in 2024 owing to the robust research and deve...
December 30, 2025
Market insights predict the global cell harvesting industry will increase from USD 6.71 billion in 2025 to USD 22.68 billion by 2035, achieving a CAGR of 12.95%. The cell harvesting market is expanding due to rising demand for cell and gene therapies as well as growing use of stem cell-based treatment approaches. North America led the market due to...
December 30, 2025
According to market projections, the global biostimulants market, valued at USD 3.06 billion in 2024, is anticipated to reach USD 6.26 billion by 2034, growing at a CAGR of 7.44% over the next decade. Biostimulants are eco-friendly tools that boost plant growth, yield, and stress resistance. In 2024, Europe led the market, while Asia Pacific is set...
December 30, 2025
According to market projections, the microRNA market will increase from $2.05 billion in 2025 to $6.89 billion by 2035, including the dominant market share held by North America at 41.6% in 2025 and the rapidly expanding Asia Pacific region, which is expected to grow at the fastest rate during the forecast period....
December 30, 2025
Forecasts suggest that the cell and gene therapy market will expand USD 232.22 billion by 2035, with a CAGR of 24% during the forecasted period. Gene therapy is rapidly evolving, driven by CRISPR and CAR-T advancements. Once focused on rare diseases and cancer, it now targets neurological, cardiovascular, and autoimmune conditions. With fast-tracke...
December 30, 2025
The biopharmaceuticals market size is calculated at $ 474.28 bn in 2025 is to hit $1540.14 bn by 2035. The biopharmaceuticals market is growing rapidly, driven by advances in biologics, personalized medicine, and gene therapy. Innovations in monoclonal antibodies, vaccines, and cell therapies are transforming treatments. Demand for biologics in chr...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com